Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Bryson Kemler

Sports Medicine Chesapeake, VA Medical Doctor

NPI 1417510678 CMS profile 11306350

667 Kingsborough Sq Ste 300, Chesapeake, VA 23320

Open in the dashboard

General payments

$45,503

127 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bryson Kemler of Chesapeake, VA is reported in the CMS Open Payments database as having received $45,503 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,992 87
2024 General $25,783 28
2023 General $116 3
2022 General $6,012 6
2021 General $3,600 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bryson Kemler
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Bryson Kemler were reported at $9,992. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Bryson Kemler Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $0 $708 $96–$2,890 $114
2021 $3,600 $1,213 $152–$3,994 $132
2022 $6,012 $1,230 $159–$3,998 $149
2023 $116 $584 $146–$2,836 $160
2024 $25,783 $628 $163–$3,168 $164
2025 $9,992 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $23,173 22 payments
  2. Smith+Nephew, Inc. $8,333 45 payments
  3. Liberty Surgical, Inc $7,200 6 payments
  4. Stryker Corporation $2,948 32 payments
  5. Eclipse Technology Solutions Inc. $1,247 4 payments
  6. Paladin Technology Solutions $1,200 1 payment
  7. Shoulder Innovations, Inc. $725 5 payments
  8. Fortis Surgical, LLC $289 4 payments
  9. Vericel Corporation $200 2 payments
  10. Saxum Surgical, Inc. $123 3 payments
  11. Other $66 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $25,833 3 payments
  2. Education $9,916 10 payments
  3. Food and Beverage $5,267 98 payments
  4. Travel and Lodging $4,462 15 payments
  5. Gift $24 1 payment
Products named General payments · program years 2021–2025
  1. MAKO Knees, Hips $1,103 8 payments
  2. N/A $866 13 payments
  3. InSet System $725 5 payments
  4. MAKO Joint Replacement Hips, Knees $701 11 payments
  5. Bone Anchors with Arthroscopic Delivery System $467 6 payments
  6. Bioinductive Implant with Arthroscopic Delivery System - Medium $462 7 payments
  7. Q-FIX $408 8 payments
  8. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $317 4 payments
  9. AEQUALIS PERFORM $316 2 payments
  10. CAP-FIX $269 4 payments
  11. Other $2,458 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

28

Median for Orthopedic Surgery: 203

Drug cost

$378

Median for Orthopedic Surgery: $1,433

Branded share of claims

46.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Monohydrate Generic 15 $227
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $152

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$3,235

Medicare's payments for the services billed

Medicare patients

17

Average age 73

Services billed

26

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record